Lucid Diagnostics Inc. Common Stock

LUCDNASDAQ • USD
ThemeMedical Devices & HealthTech›Diagnostic Imaging & Equipment
1.02 USD
↗ 0.02 (1.49%)AT CLOSE (11:59 AM EDT)
1.02
↘ 0.00 (0.10%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
1.02
↘ 0.00 (0.10%)
🔴Market: CLOSED
Open?$1.02
High?$1.04
Low?$1.00
Prev. Close?$1.01
Volume?587.7K
Avg. Volume?965.0K
VWAP?$1.02
Rel. Volume?0.61x
Bid / Ask
Bid?$1.01 × 3.0K
Ask?$1.03 × 10.0K
Spread?$0.02
Midpoint?$1.02
Valuation & Ratios
Market Cap?192.7M
Shares Out?203.1M
Float?150.5M
Float %?77.1%
P/E Ratio?N/A
P/B Ratio?48.17
EPS?-$0.30
Dividend?0.00%
Ex-Dividend?N/A

Lucid Diagnostics Inc. Common Stock (LUCD) trades at $1.02 per share. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, LUCD is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jun 4, 2026.

News
Profile
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Themes
Medical Devices & HealthTech›Diagnostic Imaging & EquipmentHealthcare - Oncology›Cancer Diagnostics & Biomarkers
Employees
82
Market Cap
191.7M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.luciddx.com
Listed
2021-10-14
Address
360 MADISON AVENUE
NEW YORK, NY 10017
Phone: 212 949 4319
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
73
Short Sent.?
38
Piotroski F-Score?4/9Mixed
Altman Z-Score?-12.95Distress
Confidence?49%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?4.40%Low
Short Interest?6.6M
Days to Cover?7.6
Free Float150.5M
Avg Daily Volume866.8K
Settlement Date2026-05-15
Financial Health
Current Ratio?1.07Adequate
Quick Ratio?1.05Adequate
Cash Ratio?0.95Adequate
Debt/Equity?6.30High
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
N/A▾
P/B?
Peers
100
S&P
3
48.17HIGH▾
P/S?
Peers
100
S&P
3
37.53HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.9CHEAP▾
EV/Sales?
Peers
100
S&P
3
37.01HIGH▾
Returns & Efficiency
ROE?
S&P
3
-1,454.5%WEAK▾
ROA?
S&P
3
-170.7%WEAK▾
Cash Flow & Enterprise
FCF?$-46440000
Enterprise Value?$190.0M
Fundamentals ratios updated end of day
MarketsMoversWatchlist